Mark Yazer
Pittsburgh, PANPI 1609842913
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,169,765 of the $2,185,783 with a category attached, or 99.3%. Vitalant accounts for 89.2% of it on its own, with 4 other manufacturers making up the rest.
Across 73 payments — averaging $29,942 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vitalant$1.9M
- Institute For Transfusion Medicine$209K
- Grifols, S.A.$18K
- Grifols Diagnostic Solutions, Inc.$5K
- Terumo BCT, Inc.$4K
Across 2 payments — averaging $960.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$2K
What the payments were for
- Consulting fees$9,8000%
- Speaking & faculty fees$2,169,76599%
- Travel & lodging$6,1550%
- Food & beverage$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vitalant | 56 | $1,949,489 |
| Institute For Transfusion Medicine | 1 | $208,951 |
| Grifols, S.A. | 10 | $18,233 |
| Grifols Diagnostic Solutions, Inc. | 2 | $5,300 |
| Terumo BCT, Inc. | 4 | $3,810 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erytra Eflexis$5,300
- Trima Accel$1,725
- Spectra Optia Apheresis System$1,500
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.